Investigations
UnitedHealth Group Incorporated
Overview
Overview
- Deadline:
- Jul 7, 2025
| Company Name: | Company Name: UnitedHealth Group Incorporated |
| Stock Symbol: | Stock Symbol: UNH |
UnitedHealth Group Incorporated (NYSE: UNH): UnitedHealth Group Incorporated (“UnitedHealth” or the “Company”) and certain of the Company’s senior executives have been sued for violations of the federal securities laws. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in UnitedHealth securities. The case is pending in the U.S. District Court for the Southern District of New York and is captioned Faller v. UnitedHealth Group Incorporated, et al., No. 25-cv-03799.
If you incurred losses on your investments in UnitedHealth, you are encouraged to submit your information.
Why was UnitedHealth Sued for Securities Fraud?
UnitedHealth is a health insurance and health care services company. The complaint alleges that the Company has long engaged in a corporate strategy of improperly denying health coverage to boost profits. This strategy led to regulatory scrutiny and public angst which ultimately resulted in the death of the CEO of the Company’s UnitedHealthcare subsidiary in December 2024. In response to the outrage, UnitedHealth eased its strategy of improperly denying health insurance claims. Despite this shift in strategy, the Company maintained the previously issued financial guidance.
The Stock Declines as the Truth is Revealed
On April 17, 2025, UnitedHealth significantly reduced its full year 2025 financial guidance which it attributed, in part, to “[h]eightened care activity indications within UnitedHealthcare’s Medicare Advantage business, . . . far above the planned 2025 increase” that “was most notable within physician and outpatient services.” Investment analysts immediately recognized that the reduced guidance marked a significant change in corporate strategy. For instance, Sanford C. Bernstein analyst Lance Wilkes commented on April 17, 2025, “I think it’s probably United pulling back because of the policy headwinds and the scrutiny on the Company . . . [t]hey are likely looking at what they need to be doing from a policy standpoint to be a more acceptable player in the U.S. healthcare system.”
On this news, the price of UnitedHealth stock declined more than 22%, from $585.04 per share on April 16, 2025, to $454.11 per share on April 17, 2025.
Then, on May 13, 2025, UnitedHealth announced the surprise immediate departure of CEO Andrew Witty and suspended its 2025 fiscal guidance. On this news, the price of UnitedHealth stock declined more than 10% during trading on May 13, 2025.
What are my Rights?
If you purchased or otherwise acquired UnitedHealth securities, you may ask the Court no later than July 7, 2025, which is the first business day after 60 days from the date of the publication of notice of pendency, to appoint you as Lead Plaintiff through counsel of your choice. To be a member of the Class, you need not take any action at this time. The ability to share in any potential future recovery is not dependent on serving as Lead Plaintiff.
If you incurred losses on your investments in UnitedHealth, you are encouraged to submit your information to speak with an attorney about your rights.
You can also contact:
Ross Shikowitz
ross@bfalaw.com
212-789-3619
All representation is on a contingency fee basis. Shareholders are not responsible for any court costs or expenses of litigation. The Firm will seek court approval for any potential fees and expenses.
Why Bleichmar Fonti & Auld LLP?
BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It was named among the Top 5 plaintiff law firms by ISS SCAS in 2023 and its attorneys have been named Titans of the Plaintiffs’ Bar by Law360 and SuperLawyers by Thompson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.
Attorney advertising. Past results do not guarantee future outcomes.
If you incurred losses on your investments in UnitedHealth, you are encouraged to submit your information.
Why was UnitedHealth Sued for Securities Fraud?
UnitedHealth is a health insurance and health care services company. The complaint alleges that the Company has long engaged in a corporate strategy of improperly denying health coverage to boost profits. This strategy led to regulatory scrutiny and public angst which ultimately resulted in the death of the CEO of the Company’s UnitedHealthcare subsidiary in December 2024. In response to the outrage, UnitedHealth eased its strategy of improperly denying health insurance claims. Despite this shift in strategy, the Company maintained the previously issued financial guidance.
The Stock Declines as the Truth is Revealed
On April 17, 2025, UnitedHealth significantly reduced its full year 2025 financial guidance which it attributed, in part, to “[h]eightened care activity indications within UnitedHealthcare’s Medicare Advantage business, . . . far above the planned 2025 increase” that “was most notable within physician and outpatient services.” Investment analysts immediately recognized that the reduced guidance marked a significant change in corporate strategy. For instance, Sanford C. Bernstein analyst Lance Wilkes commented on April 17, 2025, “I think it’s probably United pulling back because of the policy headwinds and the scrutiny on the Company . . . [t]hey are likely looking at what they need to be doing from a policy standpoint to be a more acceptable player in the U.S. healthcare system.”
On this news, the price of UnitedHealth stock declined more than 22%, from $585.04 per share on April 16, 2025, to $454.11 per share on April 17, 2025.
Then, on May 13, 2025, UnitedHealth announced the surprise immediate departure of CEO Andrew Witty and suspended its 2025 fiscal guidance. On this news, the price of UnitedHealth stock declined more than 10% during trading on May 13, 2025.
What are my Rights?
If you purchased or otherwise acquired UnitedHealth securities, you may ask the Court no later than July 7, 2025, which is the first business day after 60 days from the date of the publication of notice of pendency, to appoint you as Lead Plaintiff through counsel of your choice. To be a member of the Class, you need not take any action at this time. The ability to share in any potential future recovery is not dependent on serving as Lead Plaintiff.
If you incurred losses on your investments in UnitedHealth, you are encouraged to submit your information to speak with an attorney about your rights.
You can also contact:
Ross Shikowitz
ross@bfalaw.com
212-789-3619
All representation is on a contingency fee basis. Shareholders are not responsible for any court costs or expenses of litigation. The Firm will seek court approval for any potential fees and expenses.
Why Bleichmar Fonti & Auld LLP?
BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It was named among the Top 5 plaintiff law firms by ISS SCAS in 2023 and its attorneys have been named Titans of the Plaintiffs’ Bar by Law360 and SuperLawyers by Thompson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.
Attorney advertising. Past results do not guarantee future outcomes.